Dyne Therapeutics Inc (NASDAQ:DYN)

Delayed Data
As of Jan 27
 +0.63 / +4.44%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Dyne Therapeutics Inc have a median target of 23.00, with a high estimate of 47.00 and a low estimate of 16.00. The median estimate represents a +55.30% increase from the last price of 14.81.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Dyne Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.37%
Growthannually -15.07%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.